Water Leaders to Accelerate Action Towards UN Sustainable Development Goals at IWA World Water Congress 2022
12.9.2022 12:00:00 EEST | Business Wire | Press release
There are 2.3 billion people who now live in water-stressed countries and 18 million people risk being displaced by floods every year1. Against this backdrop, global water technology company Xylem (NYSE: XYL), will join water sector leaders at the IWA World Water Congress & Exhibition, to explore solutions to build water security. Xylem executives will share perspectives on actions to increase communities’ resilience to water scarcity, and strategies to accelerate the decarbonization of water networks.
The congress takes place in Copenhagen, Denmark, 11-15 September 2022. On Wednesday, September 14, Dave Flinton, Xylem’s Chief Innovation, Technology and Product Management Officer, will discuss the business models and multidisciplinary approaches needed for successful innovation in resource recovery. Learning to Dance in the Rain — How to Thrive in an Era of Climate Change, will explore actions taken to date and future trends.
Commenting on the congress, Dave Flinton said, “Technology can make communities more resilient in the face of severe weather. Through innovation and collaboration, we can modernize water systems so that communities have affordable, accessible water, and are buffered from shocks like droughts and floods.”
On Monday, September 12, Austin Alexander, Vice President, Sustainability and Social Impact at Xylem, will take part in a keynote plenary discussion – Practical Perspectives in Building Resilience into Urban Water Management. During the session, she will share insights on building urban resiliency in the face of climate change, the solutions that are available, and the importance of maintaining momentum on the UN SDGs. As water infrastructure is a contributor to greenhouse gas (GHG) emissions, Alexander will also touch on the use of technology to meaningfully reduce emissions and help transform the future of water management.
On Wednesday, September 14, Xylem’s Global Procurement Sustainability Manager, Andrea Montuori will participate in a keynote plenary session on Uniting Youth for Water. This session will examine the role of youth within the water sector, with a special focus on the UN 2023 Water Conference, taking place in March next year.
Xylem will also hold two business forums at the congress:
- On Tuesday, September 13, Joost Aloserij, Director of Business Development, Central & North Europe at Xylem, will lead a forum on Let's Redefine what's Possible for Water. Drawing on Xylem Vue, Xylem’s digital solutions platform that combines smart, connected technologies with intelligent systems and services. This session will focus on how utilities can embrace digital innovation to improve performance, reduce costs, and better serve their communities.
- On Wednesday, September 14, Alexis De Kerchove, Senior Director, Marketing and Business Development, Europe Commercial Team, will lead a forum on Road to Net Zero, alongside Austin Alexander. This session will explore the importance of decarbonization for water and wastewater utilities.
Xylem is also the proud sponsor of the IWA Climate Smart Utilities Recognition Program which aims to inspire utilities and all their stakeholders to become Climate Smart and embrace climate resilience under three key pillars for action – adaptation, mitigation, and leadership. Following a robust review, forty-two Climate Smart utilities will be honored at the IWA World Water Congress & Exhibition closing ceremony on Thursday, September 15.
About Xylem
Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in more than 150 countries become water secure. Join us at www.xylem.com.
______________________
1
https://www.internal-displacement.org/global-report/grid2019/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005444/en/
Contact information
Houston Spencer
+1 (914) 240-3046
Houston.Spencer@xylem.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom